We have located links that may give you full text access.
Journal Article
Multicenter Study
Medicaid expansion and chronic obstructive pulmonary disease among low-income adults in the United States.
Clinical Respiratory Journal 2018 April
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is common but often underdiagnosed in the United States (US). Public health insurance coverage expansion may increase the prevalence of diagnosed COPD due to improved access to care and diagnosis.
OBJECTIVE: We sought to determine the effects of Medicaid expansion on the prevalence of diagnosed COPD among low-income US adults.
METHODS: The 2011-2015 Behavioral Risk Factor Surveillance System survey data were used to identify adults with annual household income <$50 000. The outcome was self-report of being diagnosed with COPD by a health-care provider. Difference-in-difference logistic regression contrasted the influence of period (pre-expansion, 2011-2013, vs post-expansion, 2014-2015) between states participating and opting out of Medicaid expansion.
RESULTS: Data on 521 622 respondents were analysed. The prevalence of diagnosed COPD was 7% in Medicaid expansion states and 8% in non-participating states. In participating states, lack of health insurance among low-income adults decreased from 32% to 21% after Medicaid expansion (P < .001), but the prevalence of diagnosed COPD was unchanged. Multivariable logistic regression confirmed that residents of participating states surveyed after Medicaid expansion were no more likely to report diagnosed COPD than residents of these states surveyed before Medicaid expansion (OR = 1.03; 95% CI: 0.97, 1.10; P = .276).
CONCLUSIONS: Notwithstanding increased health insurance coverage among low-income adults after Medicaid expansion, this policy did not increase the prevalence of diagnosed COPD. Access to primary care among new Medicaid enrollees and practices of diagnosing COPD in this setting should be evaluated to reduce the extent of undiagnosed COPD in socioeconomically disadvantaged groups.
OBJECTIVE: We sought to determine the effects of Medicaid expansion on the prevalence of diagnosed COPD among low-income US adults.
METHODS: The 2011-2015 Behavioral Risk Factor Surveillance System survey data were used to identify adults with annual household income <$50 000. The outcome was self-report of being diagnosed with COPD by a health-care provider. Difference-in-difference logistic regression contrasted the influence of period (pre-expansion, 2011-2013, vs post-expansion, 2014-2015) between states participating and opting out of Medicaid expansion.
RESULTS: Data on 521 622 respondents were analysed. The prevalence of diagnosed COPD was 7% in Medicaid expansion states and 8% in non-participating states. In participating states, lack of health insurance among low-income adults decreased from 32% to 21% after Medicaid expansion (P < .001), but the prevalence of diagnosed COPD was unchanged. Multivariable logistic regression confirmed that residents of participating states surveyed after Medicaid expansion were no more likely to report diagnosed COPD than residents of these states surveyed before Medicaid expansion (OR = 1.03; 95% CI: 0.97, 1.10; P = .276).
CONCLUSIONS: Notwithstanding increased health insurance coverage among low-income adults after Medicaid expansion, this policy did not increase the prevalence of diagnosed COPD. Access to primary care among new Medicaid enrollees and practices of diagnosing COPD in this setting should be evaluated to reduce the extent of undiagnosed COPD in socioeconomically disadvantaged groups.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app